{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:33:46Z","timestamp":1790692426658,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.prro.2025.10.004","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:08:15Z","timestamp":1762308495000},"page":"e219-e227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in Prostate Brachytherapy Utilization in the United States and Implications for Resident Training"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4243-5385","authenticated-orcid":false,"given":"Evrosina I.","family":"Isaac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Basree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Peter F.","family":"Orio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catheryn M.","family":"Yashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Kamrava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2025.10.004_bib0001","unstructured":"American Cancer Society. Key statistics for prostate cancer. Accessed February 10, 2025. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html"},{"key":"10.1016\/j.prro.2025.10.004_bib0002","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.brachy.2021.07.006","article-title":"Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement","volume":"20","author":"King","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2025.10.004_bib0003","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.brachy.2025.06.005","article-title":"High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statement","volume":"24","author":"Patel","year":"2025","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2025.10.004_bib0004","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.radonc.2021.12.047","article-title":"UROGEC group of GEC ESTRO with endorsement by the European Association of Urology. GEC-ESTRO ACROP prostate brachytherapy guidelines","volume":"167","author":"Henry","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.10.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110979","article-title":"GEC-ESTRO. Salvage brachytherapy for local recurrence of cancer after definitive irradiation: A GEC-ESTRO narrative review","volume":"209","author":"Hannoun-Levi","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.10.004_bib0006","article-title":"A threat to quality cancer care, accessibility, and sustainability: Medicare payment policies and changing utilization patterns in radiation oncology","volume":"17","author":"Patel","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.prro.2025.10.004_bib0007","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.brachy.2019.10.006","article-title":"Resident experience in brachytherapy: An analysis of accreditation council for graduate medical education case logs for intracavitary and interstitial brachytherapy from 2007 to 2018","volume":"19","author":"Shinde","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2025.10.004_bib0008","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ijrobp.2018.10.023","article-title":"Brachytherapy training survey of radiation oncology residents","volume":"103","author":"Marcrom","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.004_bib0009","unstructured":"Centers for Medicare and Medicaid Services, Office of Enterprise Data and Analytics. Medicare Fee-For-Service provider utilization & payment data physician and other practitioners dataset: A methodological overview. Accessed February 10, 2025.https:\/\/data.cms.gov\/sites\/default\/files\/2024-06\/MUP_PHY_RY24_20240530_Methodology_508_0.pdf"},{"key":"10.1016\/j.prro.2025.10.004_bib0010","unstructured":"Economic Research Service. Rural-urban commuting area codes. Accessed August 26, 2025. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes"},{"key":"10.1016\/j.prro.2025.10.004_bib0011","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2016.07.013","article-title":"Prostate brachytherapy case volumes by academic and nonacademic practices: Implications for future residency training","volume":"96","author":"Orio","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.004_bib0012","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.brachy.2016.05.001","article-title":"The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness","volume":"15","author":"Orio","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2025.10.004_bib0013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2021.07.004","article-title":"PSA: Declining utilization of prostate brachytherapy","volume":"21","author":"Andring","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2025.10.004_bib0014","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO-25-00274","article-title":"Focal boost to the Intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: 10-year outcomes of the FLAME trial","volume":"43","author":"Menne Guricov\u00e1","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.004_bib0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.semradonc.2025.04.006","article-title":"Debate 2: Primary localized prostate cancer: The case for whole-gland brachytherapy boost","volume":"35","author":"Chowdhury","year":"2025","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.prro.2025.10.004_bib0016","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semradonc.2025.04.005","article-title":"Debate 2: The case for focal external beam radiation therapy boost over brachytherapy boost for prostate cancer","volume":"35","author":"Dornisch","year":"2025","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.prro.2025.10.004_bib0017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.brachy.2018.01.013","article-title":"Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy","volume":"17","author":"Dutta","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2025.10.004_bib0018","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2025.10.004_bib0019","unstructured":"ClinicalTrials.gov. The phase III \u2018High Five Trial\u2019 five fraction radiation for high-risk prostate cancer. Accessed September 2, 2025. https:\/\/clinicaltrials.gov\/study\/NCT05946213"},{"key":"10.1016\/j.prro.2025.10.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2025.103909","article-title":"The Royal College of Radiologists\u2019 re-audit of UK prostate brachytherapy delivery","volume":"46","author":"Challapalli","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.prro.2025.10.004_bib0021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2020.07.036","article-title":"Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada","volume":"152","author":"Corkum","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.10.004_bib0022","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.eururo.2024.11.006","article-title":"Whole-gland or subtotal high-intensity focused ultrasound versus radical prostatectomy: The prospective, noninferiority, nonrandomized HIFI trial","volume":"87","author":"Ploussard","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2025.10.004_bib0023","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging-guided vs computed tomography-guided stereotactic body radiotherapy for prostate cancer: The MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2025.10.004_bib0024","unstructured":"Centers for Disease Control and Prevention. US prostate cancer incidence rates by state. Heart disease and stroke maps. Accessed April 27, 2025. https:\/\/www.cdc.gov\/heart-disease-and-stroke-data\/data-vis\/us-prostate-cancer.html"},{"key":"10.1016\/j.prro.2025.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ijrobp.2020.11.055","article-title":"Influence of geography on prostate cancer treatment","volume":"109","author":"Tang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.004_bib0026","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brachy.2021.05.004","article-title":"Geographic access to brachytherapy services in the United States","volume":"21","author":"Bates","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2025.10.004_bib0027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijrobp.2025.03.035","article-title":"Trends in program satisfaction and perceived confidence levels among United States radiation oncology residents: A 5-year aggregate analysis of the 2020-2024 association of residents in radiation oncology graduating resident survey","volume":"123","author":"Basree","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.004_bib0028","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2022.10.030","article-title":"Brachytherapy training survey among radiation oncology residents in Europe","volume":"177","author":"Sturdza","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.10.004_bib0029","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijrobp.2025.02.050","article-title":"Results of the 2020-2023 association of residents in radiation oncology graduating resident survey: Job search experience and satisfaction","volume":"123","author":"LeCompte","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.004_bib0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijrobp.2023.08.046","article-title":"Trimodality therapy with iodine-125 brachytherapy, external beam radiation therapy, and short- or long-term androgen deprivation therapy for high-risk localized prostate cancer: Results of a multicenter, randomized phase 3 trial (TRIP\/TRIGU0907)","volume":"118","author":"Yorozu","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.004_bib0031","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13014-023-02375-5","article-title":"Use of focal radiotherapy boost for prostate cancer: radiation oncologists\u2019 perspectives and perceived barriers to implementation","volume":"18","author":"Zhong","year":"2023","journal-title":"Radiat Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025002607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025002607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T10:34:54Z","timestamp":1778063694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850025002607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1879850025002607"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2025.10.004","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Prostate Brachytherapy Utilization in the United States and Implications for Resident Training","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2025.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}